These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25773782)

  • 1. Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulation.
    Engman C; Wen Y; Meng WS; Bottino R; Trucco M; Giannoukakis N
    Clin Immunol; 2015 Sep; 160(1):103-23. PubMed ID: 25773782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.
    Phillips B; Nylander K; Harnaha J; Machen J; Lakomy R; Styche A; Gillis K; Brown L; Lafreniere D; Gallo M; Knox J; Hogeland K; Trucco M; Giannoukakis N
    Diabetes; 2008 Jun; 57(6):1544-55. PubMed ID: 18316361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells.
    DiPaolo RJ; Brinster C; Davidson TS; Andersson J; Glass D; Shevach EM
    J Immunol; 2007 Oct; 179(7):4685-93. PubMed ID: 17878367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
    Kaminitz A; Mizrahi K; Askenasy N
    Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
    Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
    J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring and Modulation of Inducible Foxp3
    Veenbergen S; van Berkel LA; du Pré MF; Kozijn AE; Samsom JN
    Methods Mol Biol; 2017; 1559():241-254. PubMed ID: 28063048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes.
    Chen YG; Choisy-Rossi CM; Holl TM; Chapman HD; Besra GS; Porcelli SA; Shaffer DJ; Roopenian D; Wilson SB; Serreze DV
    J Immunol; 2005 Feb; 174(3):1196-204. PubMed ID: 15661873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.
    Chen Z; Herman AE; Matos M; Mathis D; Benoist C
    J Exp Med; 2005 Nov; 202(10):1387-97. PubMed ID: 16301745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
    Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
    J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 Knocked Down Tolerogenic Dendritic Cells Decrease Diabetic Injury.
    Mahmoudzadeh A; Pourfathollah AA; Karimi MH; Moazzeni SM
    Iran J Immunol; 2017 Dec; 14(4):270-280. PubMed ID: 29276180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.
    Machen J; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
    J Immunol; 2004 Oct; 173(7):4331-41. PubMed ID: 15383562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice.
    Tang Q; Adams JY; Tooley AJ; Bi M; Fife BT; Serra P; Santamaria P; Locksley RM; Krummel MF; Bluestone JA
    Nat Immunol; 2006 Jan; 7(1):83-92. PubMed ID: 16311599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
    PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
    [TBL] [Abstract]